RT Journal Article
SR Electronic
T1 Operationalizing a routine wastewater monitoring laboratory for SARS-CoV-2
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.06.21258431
DO 10.1101/2021.06.06.21258431
A1 Rose S. Kantor
A1 Hannah D. Greenwald
A1 Lauren C. Kennedy
A1 Adrian Hinkle
A1 Sasha Harris-Lovett
A1 Matthew Metzger
A1 Melissa M. Thornton
A1 Justin M. Paluba
A1 Kara L. Nelson
YR 2021
UL http://medrxiv.org/content/early/2021/06/09/2021.06.06.21258431.abstract
AB Wastewater-based testing for SARS-CoV-2 is a novel tool for public health monitoring, but additional laboratory capacity is needed to provide routine monitoring at all locations where it has the potential to be useful. Few standardization practices for SARS-CoV-2 wastewater analysis currently exist, and quality assurance/quality control procedures may vary across laboratories. Alongside counterparts at many academic institutions, we built out a laboratory for routine monitoring of wastewater at the University of California, Berkeley. Here, we detail our group’s establishment of a wastewater testing laboratory including standard operating procedures, laboratory buildout and workflow, and a quality assurance plan. We present a complete data analysis pipeline and quality scoring framework and discuss the data reporting process. We hope that this information will aid others at research institutions, public health departments, and wastewater agencies in developing programs to support wastewater monitoring for public health decision-making.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding was provided by the Catena Foundation, the Innovative Genomics Institute at University of California, Berkeley, and the Center for Information Technology Research in the Interest of Society. No third party payments or services were received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesExtended data are available upon request.